Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Benati D, Galperin M, Lambotte O, Gras S, Lim A, Mukhopadhyay M, Nouël A, Campbell KA, Lemercier B, Claireaux M, Hendou S, Lechat P, de Truchis P, Boufassa F, Rossjohn J, Delfraissy JF, Arenzana-Seisdedos F, Chakrabarti LA.

J Clin Invest. 2016 Jun 1;126(6):2093-108. doi: 10.1172/JCI83792.

2.

Identification of global regulators of T-helper cell lineage specification.

Kanduri K, Tripathi S, Larjo A, Mannerström H, Ullah U, Lund R, Hawkins RD, Ren B, Lähdesmäki H, Lahesmaa R.

Genome Med. 2015 Nov 20;7:122. doi: 10.1186/s13073-015-0237-0.

3.

Short Communication: Expression of APOBEC3G and Interferon Gamma in Pleural Fluid Mononuclear Cells from HIV/TB Dual Infected Subjects.

Toossi Z, Meng Q, Aung H, Liu S, Mayanja-Kizza H, Hirsch CS.

AIDS Res Hum Retroviruses. 2015 Jul;31(7):692-5. doi: 10.1089/AID.2014.0297.

4.

Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk.

Imahashi M, Izumi T, Watanabe D, Imamura J, Matsuoka K, Ode H, Masaoka T, Sato K, Kaneko N, Ichikawa S, Koyanagi Y, Takaori-Kondo A, Utsumi M, Yokomaku Y, Shirasaka T, Sugiura W, Iwatani Y, Naoe T.

PLoS One. 2014 Mar 25;9(3):e92861. doi: 10.1371/journal.pone.0092861.

5.

Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches.

Santa-Marta M, de Brito PM, Godinho-Santos A, Goncalves J.

Front Immunol. 2013 Oct 24;4:343. doi: 10.3389/fimmu.2013.00343. Review.

6.

Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.

De Pasquale M, Kourteva Y, Allos T, D'Aquila RT.

PLoS One. 2013 Oct 16;8(10):e76002. doi: 10.1371/journal.pone.0076002.

7.

Mapping the LINE1 ORF1 protein interactome reveals associated inhibitors of human retrotransposition.

Goodier JL, Cheung LE, Kazazian HH Jr.

Nucleic Acids Res. 2013 Aug;41(15):7401-19. doi: 10.1093/nar/gkt512.

8.

HIV restriction by APOBEC3 in humanized mice.

Krisko JF, Martinez-Torres F, Foster JL, Garcia JV.

PLoS Pathog. 2013 Mar;9(3):e1003242. doi: 10.1371/journal.ppat.1003242.

9.

APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.

Kourteva Y, De Pasquale M, Allos T, McMunn C, D'Aquila RT.

Virology. 2012 Aug 15;430(1):1-9. doi: 10.1016/j.virol.2012.03.018.

10.

The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict.

Compton AA, Hirsch VM, Emerman M.

Cell Host Microbe. 2012 Jan 19;11(1):91-8. doi: 10.1016/j.chom.2011.11.010.

11.

Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.

Mussil B, Sauermann U, Motzkus D, Stahl-Hennig C, Sopper S.

Retrovirology. 2011 Sep 28;8:77. doi: 10.1186/1742-4690-8-77.

12.

Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.

Amoêdo ND, Afonso AO, Cunha SM, Oliveira RH, Machado ES, Soares MA.

PLoS One. 2011;6(8):e24118. doi: 10.1371/journal.pone.0024118.

13.

APOBEC3G complexes decrease human immunodeficiency virus type 1 production.

Martin KL, Johnson M, D'Aquila RT.

J Virol. 2011 Sep;85(18):9314-26. doi: 10.1128/JVI.00273-11. Erratum in: J Virol. 2012 Aug;86(16):8916.

14.

N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Wang Y, Shao Q, Yu X, Kong W, Hildreth JE, Liu B.

J Virol. 2011 May;85(9):4510-9. doi: 10.1128/JVI.01925-10.

15.

Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Thippeshappa R, Polacino P, Yu Kimata MT, Siwak EB, Anderson D, Wang W, Sherwood L, Arora R, Wen M, Zhou P, Hu SL, Kimata JT.

J Virol. 2011 Apr;85(8):3767-79. doi: 10.1128/JVI.02438-10.

16.

NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Farrow MA, Kim EY, Wolinsky SM, Sheehy AM.

J Biol Chem. 2011 Jan 28;286(4):2567-77. doi: 10.1074/jbc.M110.154377.

17.

Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.

Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, Dejean A, Wain-Hobson S.

PLoS Pathog. 2010 May 27;6(5):e1000928. doi: 10.1371/journal.ppat.1000928.

18.

Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, Hu WS, Pathak VK.

J Virol. 2010 Jun;84(11):5719-29. doi: 10.1128/JVI.00134-10.

19.

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS.

Nucleic Acids Res. 2010 Jul;38(13):4274-84. doi: 10.1093/nar/gkq174.

20.

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Albin JS, Harris RS.

Expert Rev Mol Med. 2010 Jan 22;12:e4. doi: 10.1017/S1462399409001343. Review.

Items per page

Supplemental Content

Support Center